This week, three Medical Devices stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
This week, Spectranetics (NASDAQ:SPNC) is showing good progress as the company’s rating jumps from a B (“buy”) last week to an A (“strong buy”). The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system, many of which are used with its proprietary excimer laser system. In Portfolio Grader’s specific subcategories of Earnings Momentum, Earnings Revisions, Earnings Surprise, and Margin Growth, SPNC also gets A’s. The stock price has risen 6.3% over the past month, better than the 0.3% the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of SPNC stock.
Anika Therapeutics (NASDAQ:ANIK) is bettering its rating of C (“hold”) from last week to a B (“buy”) this week. Anika Therapeutics develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. Wall Street seems to agree with the upgrade and has propelled the stock up 9.2% over the past month. For more information, get Portfolio Grader’s complete analysis of ANIK stock.
This week, Cardiovascular Systems’ (NASDAQ:CSII) ratings are up from a C last week to a B. Cardiovascular Systems focuses on developing and commercializing minimally invasive treatment solutions for vascular disease. For more information, get Portfolio Grader’s complete analysis of CSII stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.